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A B S T R A C T
During a viral infection, in addition to cellular mRNAs, amounts of viral mRNAs have to be efﬁciently
transported to the cytoplasm for translation. It is now established that herpesviruses encode a conserved
gene family whose proteins act as viral mRNA export factors that mediate nucleocytoplasmic transport
of viral transcripts and eventually modulate through this mechanism the antiviral response. This
conserved family of proteins contains the IE4 protein of the Varicella-Zoster virus (VZV). Here, we
compared the functional characteristics of IE4 with those of its herpesviral homologues and proposed a
model by which IE4 would be able to recruit the essential TAP/NXF1 receptor to viral transcripts.
Moreover, on the basis of their crucial roles in the infectious cycle, these conserved viral factors should be
considered as alternative targets in therapeutic approaches. Here, we discussed the possibility of
developing antiherpetic agents targeting IE4 or its herpesviral homologues.
 2010 Elsevier Inc. All rights reserved.
Contents lists available at ScienceDirect
Biochemical Pharmacology
journal homepage: www.e lsev ier .com/ locate /b iochempharm1. Introduction
Herpesviruses are DNA viruses whose genome is transcribed in
three successive phases within the nucleus of the infected cells.
Generally, in response to a viral infection, the host immune system
reacts and sets up an inﬂammatory response aiming to eradicate
the viral progression. Herpesviruses are known to induce such an
innate immune response during acute infection. In parallel,* Corresponding author. Tel.: +32 4 366 2442; fax: +32 4 366 2433.
E-mail addresses: csadzot@ulg.ac.be, jpiette@ulg.ac.be (C. Sadzot-Delvaux).
0006-2952/$ – see front matter  2010 Elsevier Inc. All rights reserved.
doi:10.1016/j.bcp.2010.07.011herpesviruses have also been described as being able to escape
these antiviral responses. In this perspective, herpesviruses encode
proteins that are known to interfere with the host immunity and
whose expression was shown to be required to inhibit some
antiviral responses. Among these proteins, a conserved family of
herpesviral proteins has been described to interfere with the post-
transcriptional gene regulation through the cellular machinery of
mRNA splicing, stability, export and translation. This family
contains the ICP27 protein of the herpes simplex virus type-1
(HSV-1), the UL69 protein of the human cytomegalovirus (HCMV),
and the EB2 protein of the Epstein-Barr virus (EBV), respectively
alpha-, beta- and gamma-herpesviruses. The IE4 protein, encoded
[(Fig._1)TD$FIG]
Fig. 1. Organization of the different functional domains of the herpesviral homologues. ICP27 of the herpes simplex virus type-1 (HSV-1) from the alpha-herpesvirus
subfamily. UL69 of the human cytomegalovirus (HCMV) from the beta-herpesvirus subfamily. EB2 of the Epstein-Barr virus (EBV) from the gamma-herpesvirus subfamily. IE4
of the Varicella-Zoster virus (VZV) from the alpha-herpesvirus subfamily. NES, nuclear export signal; NLS, nuclear localization signal; RBD, RNA-binding domain; TAP/NXF1,
Aly/REF, UAP56, SRPK1 and SR proteins, binding sites of the respective cellular proteins; IE4 and UL97, binding sites of the respective viral proteins. The phosphorylation sites
discussed in the text are shown by black stars.
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Fig. 2. Comparison of the different nuclear localization signals (NLSs) sequences.
The HSV-1 ICP27 NLS bears similarity with the bipartite Xenopus laevis
nucleoplasmin NLS (underlined). The HCMV UL69 NLS is an arginine-rich
(indicated in bold) region which resembles a bipartite NLS. The EBV EB2 NLS
contains two independent KH-rich motifs (underlined). The VZV IE4 NLS was
proposed to correspond to the basic arginine-rich (indicated in bold) region
mapping to residues 130–143. Numbers refer to the positions of the amino acid
sequences within each protein.
[(Fig._3)TD$FIG]
Fig. 3. Comparison of the different nuclear export signals (NESs) sequences. The
HSV-1 ICP27 NES is a leucine-rich NES similar to the HIV-1 REV NES. The conserved
amino acids are shown in bold. The HCMV UL69 NES is a 28-amino acid domain
whose essential residues are indicated is bold. The EBV EB2 NES is a leucine-rich
regionmapping to residues 61–140. A leucine-richmotif found into the central part
of VZV IE4 could correspond to an NES. Numbers refer to the positions of the amino
acid sequences within each protein.
I. Ote et al. / Biochemical Pharmacology 80 (2010) 1973–1980974by the Varicella-Zoster virus (VZV), another alpha-herpesvirus,
also belongs to this conserved family and its characteristics will be
compared in this review with those of its homologues.
2. The herpesviral mRNA export factors
Structurally, HSV-1 ICP27, HCMV UL69, EBV EB2 and VZV IE4
share an overall amino acid homology ranging between 20% and
30%. Moreover, they all contain, within their C-terminal part, a
homology region whose homology with ICP27 can be as high as
40–60% (Fig. 1) [1,2]. Functionally, ICP27, UL69 and EB2 were all
originally described as trans-regulatory proteins and it was
initially assumed that their stimulatory functions on gene
expression, from various viral as well as cellular promoters,
occurred at the transcriptional level. Progressively, this transacti-
vation appeared to occur at the RNA level, suggesting a post-
transcriptional mechanism. Years later, it is now clearly demon-
strated that these proteins share common characteristics, such as a
nucleocytoplasmic shuttling activity, an RNA-binding domain
(RBD) and the capacity to interact with cellular mRNA export
factors, which identify them as viral mRNA export factors (Fig. 1).
Available data suggested that IE4 also acts as an important
regulator on VZV and cellular genes expression and could exert its
functions at a post-transcriptional level. Although the molecular
mechanisms are not yet fully characterized, we have recently
shown that IE4 also shares the common characteristics of these
herpesviral export factors [3].
3. Their nucleocytoplasmic shuttling activity
All members of this protein family have been reported to
shuttle between the nucleus and the cytoplasm independently of
virus-encoded cofactors indicating that it is an intrinsic character-
istic [4–7]. Generally, nucleocytoplasmic protein trafﬁcking occurs
through direct interactions between the transport signals NLS and
NES on the proteins and import or export receptors that mediate
passage through the nuclear pore complex (NPC).
Nuclear localization signals (NLSs) have been described for the
four homologues but they differ from each other (Fig. 2). First,
ICP27 was shown to possess a strong NLS, mapping to residues
110–137, which bears similarity with the bipartite NLS found in
Xenopus laevis nucleoplasmin. Moreover, the sequence mapping to
residues 110–152, including this strong NLS and the 15 contiguous
residues which consist entirely of arginine and glycine residues,was demonstrated to function as nucleolar localization signal
(NuLS) [8]. In contrast to ICP27, UL69 localizes within the nucleus
but is excluded from the nucleolus [2]. It was also shown to contain
an arginine-rich region at the N-terminus which resembles a
bipartite NLS [6]. Similarly, EB2 was shown to contain two KH-rich
motifs,mapping to residues 127–130 and 143–145,which function
as two independent NLS sequences [9]. A basic arginine-rich
region, mapping to residues 130–143, was also described in the N-
terminal part of IE4 andwas proposed to be good candidate for NLS
[7].
Evenmore different nuclear export signals (NESs) are present in
the sequence of these viral proteins (Fig. 3). Most of the known
shuttling proteins use a leucine-rich NES similar to that of HIV-1
REV, which directly interacts with CRM-1 nuclear export receptor
I. Ote et al. / Biochemical Pharmacology 80 (2010) 1973–1980 1975to be transported into the cytoplasm. This CRM-1-dependent
nuclear export can be blocked by the antibiotic leptomycin B
(LMB), which prevents the association of NES-containing proteins
withCRM-1 [10].Whereas ICP27 and EB2possess a leucine-richNES
located in their N-terminal part, the requirement of CRM-1 for their
shuttling has been much discussed. Since initial studies suggested
that a LMB-sensitive leucine-rich region could be involved in the
nucleocytoplasmic shuttling of EB2 [5,11], later studies identiﬁed
the unique sequence responsible for the EB2 shuttling that was
showntobeLMB-insensitive [9,12]. Similarly, althoughtheexportof
ICP27 was ﬁrst reported to be sensitive to LMB [13,14], the leucine-
rich N-terminal sequence that is required for an efﬁcient ICP27
export was further shown to function as a CRM-1-independent NES
[15,16]. Singularly, anovel typeofLMB-insensitiveexport signalwas
identiﬁed within the UL69 unique C-terminal region [6]. This 28-
amino acid domain is not a leucine-rich one and the export pathway
used by this unique NES has not yet been deﬁned.Whereas VZV IE4
exhibits amainly cytoplasmic localization and should bear a nuclear
export signal, no classical NES sequence can be found within its N-
terminal region. However, a putative sequence rich in leucine
residues can be seen into the central part of the protein and could
correspondtoanNES, but the functionalityof thisputative signalhas
never been demonstrated [7].
4. Their RNA-binding domains
Another characteristic of all known viral mRNA export factors is
the presence of an RNA-binding domain (Fig. 4). ICP27 was shown
to require an arginine–glycine-rich region, mapping to residues
138–152, that constitutes an RGG box RNA-binding domain [17].
Recently, three arginine residues within this RGG box were shown
to be methylated in vivo but this methylation appears to regulate
protein–protein interactions of ICP27 in the cytoplasm rather than
RNA binding [18]. In contrast, EB2was demonstrated to harbour an
RNA-binding motif in a 33-amino acid segment that has the
structural features of arginine-rich RNA-binding motifs (ARMs)
also found in many RNA-binding proteins [19]. This region
contains a short sequence rich in arginine and lysine residues,
TRKQAR,which is characteristic of ARMs. However, since thismotif
is not sufﬁcient by itself to ensure RNA binding, additional amino
acids present in the 33-amino acid segment are required for
speciﬁc contacts with RNA. Likewise, three N-terminal arginine-
richmotifs, termed R1, R2 and RS, are required for the RNA-binding
activity of UL69 [20]. Both R1 and R2 show similarity with ARMs
which have been identiﬁed in number of viral RNA-binding
proteins and may function as a bipartite ARM. Removal of RS in
combination with either R1 or R2 abolishes the RNA-binding
[(Fig._4)TD$FIG]
Fig. 4. Comparisonof thedifferent RNA-binding domains (RBDs) sequences. TheHSV-
1 ICP27 RNA-binding domain is constituted by a RGG box. All arginine residues are
indicated in bold and the threemethylated arginine residues aremarked by asterisks.
TheHCMVUL69RNA-bindingdomain contains threearginine-rich (indicated inbold)
motifs, termed R1, R2 and RS (underlined). The EBV EB2 RNA-binding domain is an
arginine-rich (indicated in bold) region that contains a short sequence (underlined)
characteristic of ARMs. The VZV IE4 RNA-binding domainmaps to the three arginine-
rich (indicated in bold) motifs, termed Ra, Rb and Rc (underlined). Numbers refer to
the positions of the amino acid sequences within each protein.activity of UL69 both in vitro and in vivo. Recently, we have shown
that IE4 is able to bind directly to RNA in vitro and the three N-
terminal arginine-rich domains Ra, Rb and Rc of IE4 were
implicated in this interaction [3].
Although one might assume that protein domains with
numerous arginine residues bind non-speciﬁcally to RNA, se-
quence-speciﬁc interactions were demonstrated for the majority
of the ARM-containing proteins investigated so far which includes
the HIV-1 proteins REV and TAT or the phage lN protein. Although
there is no evidence for sequence-speciﬁc RNA-binding by ICP27,
EB2 and UL69 in vitro [17,19,20], several data suggest the existence
of a mechanism that confers speciﬁcity for the recognition of RNA
in vivo (reviewed in Ref. [21]). Likewise, although the RNA-binding
speciﬁcity of IE4 is still to be further explored, preliminary data in
infection suggest that the mechanism could be transcript- or gene
class-dependent [3]. Since all these herpesviral mRNA export
factors interact with several viral and cellular proteins, it is
conceivable that some of these interactions may be needed to
confer speciﬁcity to RNA recognition. In addition, the secondary
structure of RNA may be crucial for its correct recognition.
5. Their interactions with cellular mRNA export factors
In metazoans, mature and well-processed mRNPs are trans-
ported into the cytoplasm by the essential export factor TAP/NXF1.
This mRNA export receptor shuttles between the nucleus and the
cytoplasm, and escorts competent mRNPs out of the nucleus
through direct interaction with nucleoporins lining the NPC [22].
Because of its low afﬁnity for binding mRNAs, TAP/NXF1 requires
adaptor proteins to interface with mature transcripts ready for
export. So far, the best-characterized adaptor of TAP/NXF1 is the
Aly/REF protein [23], whose recruitment to mRNAs was shown to
depend on the presence of UAP56 [24]. However, the observation
that Aly/REF is dispensable for mRNA export in both Drosophila
and C. elegans suggests the existence of additional mRNA export
adaptors [25,26]. The shuttling SR proteins have recently been
proposed to act as adaptor of TAP/NXF1 and have been shown to
promote export of both intronless [27] and intron-containing [28]
mRNAs. Furthermore, SRp20 and 9G8 were shown to directly
interact with TAP/NXF1 [28,29] in a phosphorylation-dependent
manner [30,31].
Thus, besides their ability to bind RNA, the capacity of the
herpesviral proteins to interact with factors of the cellular mRNA
export machinery was also demonstrated. However, the way by
which these proteins interfere with the cellular mRNA export
pathway is not unique (Fig. 1).
In one hand, ICP27 and EB2 were shown to interact with the
mRNA export receptor TAP/NXF1 and its adaptor Aly/REF. The C-
terminal leucine-rich region of EB2 was shown to be implicated in
the interaction with Aly/REF in vitro. Aly/REF co-immunoprecipi-
tates also with EB2 from transfected cells through interaction with
the same region, but this interaction is RNase-sensitive suggesting
that in vivo these proteins are part of a ribonucleoprotein complex
stabilized by RNA [9]. This Aly/REF binding motif was shown to be
required for both EB2-mediated mRNA export and production of
infectious virions. In addition to its indirect recruitment via Aly/
REF, TAP/NXF1 was also shown to directly interact with the N-
terminal NES of EB2, containing several arginine-rich domains that
cooperate to allow efﬁcient interaction with TAP/NXF1 [32]. On its
side, ICP27 was reported to interact with TAP/NXF1 either directly
or through its interaction with Aly/REF. In infected cells, ICP27 was
shown to relocate Aly/REF from sites of cellular splicing to sites of
viral transcription [16]. This interaction with Aly/REF was ﬁrst
shown to occur through the ICP27 region that contains the RNA-
binding domain [15], and was later demonstrated to be RNase-
sensitive, conﬁrming that RNA also stabilizes the complex [9].
I. Ote et al. / Biochemical Pharmacology 80 (2010) 1973–19801976Direct interaction with TAP/NXF1 itself requires both ICP27 N-
terminus and C-terminus [33], and was shown to be essential for
both efﬁcient export of viral transcripts andHSV-1 replication [34].
On the other hand, UL69 has not yet been shown to interact with
Aly/REF or TAP/NXF1. Instead, UL69 was demonstrated to directly
bind to thehighly relatedcellularDEXD/H-boxRNAhelicasesUAP56
and URH49 [20,35]. The interaction between UL69 and UAP56/
URH49wasdemonstratedboth in transfectedand infected cells, and
itwas excluded that RNAacts as bridging factor since the complexes
areRNase-insensitive. Therefore, in contrast to ICP27andEB2, direct
RNA-binding is dispensable for UL69 RNA export activity. Compar-
atively, bothUAP56 interaction andnucleocytoplasmic shuttling are
prerequisites for this UL69 function [20].
In the case of IE4, we showed that the protein interacts in vivo
with the three shuttling SR proteins SRp20, 9G8 and ASF/SF2 [3].
This interaction, which is not bridged by RNA, was shown to occur
through the N-terminal arginine-rich domains of IE4. Contrasting-
ly, we showed that the recruitment of TAP/NXF1 by IE4 is RNase-
sensitive, which suggests that it occurs through the SR proteins
binding and that the presence of RNA stabilizes these complexes.
Thus, although speciﬁcities exist, all the data suggest that the
herpesviral mRNA export factors use a general mechanism in
which they bind to speciﬁc viral mRNAs and recruit these
transcripts to the cellular mRNA export TAP/NXF1 pathway
through direct interaction with the receptor TAP/NXF1 or with
one of its adaptors such as Aly/REF, UAP56/URH49 or the shuttling
SR proteins.
6. Their functions in the RNA export
Very early, ICP27-mediated gene regulation was suggested to
occur post-transcriptionally at the level of RNA processing [36].
Few years later, ICP27 was suggested to be involved in the
nucleocytoplasmic RNA transport of virus intron-containing
transcripts [37]. It was then demonstrated that ICP27 binds
speciﬁcally to viral intronless mRNAs in both cellular compart-
ments [38], indicating a direct role in the nuclear export of viral
mRNAs. The shuttling of ICP27 has been also reported to mediate
the expression of some viral late genes [39]. During the last 10
years, the role of ICP27 in RNA export has been extensively
documented (reviewed in Refs. [40,41]). Recently, a microarray
analysis has demonstrated that efﬁcient export of the majority of
viral transcripts requires that ICP27 be able to bind RNA and to
interact with TAP/NXF1 [42]. Furthermore, the knockdown of TAP/
NXF1 was shown to result in barely detectable level of two late
proteins gB and gC, and in greatly reduced HSV-1 viral titers [34].
Very recently, the knockdown of SRp20 and 9G8was also shown to
reduce the virus growth, suggesting that these factors could play a
role as HSV-1mRNAs export adaptors and contribute to the overall
export efﬁciency during HSV-1 infection [43].
Similarly, EB2 has been described to lead to an increased
cytoplasmic accumulation of many mRNAs, including those from
reporter genes and those from a subset of EBV early genes coding
for essential proteins involved in the EBV DNA replication during
the productive cycle [44]. Furthermore, EB2 has been shown to be
essential for the production of infectious viral particles [45] and for
the nuclear export of most, but not all, late mRNAs produced from
genes implicated in the capsid assembly and maturation [46].
In contrast, while the required domains of UL69 and its cellular
partners begin to be well deﬁned, its RNA export activity has been
only visualized in reporter assays [20,35] and the viral targets of
UL69 are still to be deﬁned. Alternatively, since UL69 is also a
constituent of HCMV virions, RNA-binding by UL69 might be
involved in the packaging of RNAs into HCMV viral particles, which
incorporate a subset of viral and cellular transcripts in the course of
infection.Recently, we showed that IE4 also inﬂuences export of a
reporter mRNA and that the knockdown of TAP/NXF1 prevents this
IE4-mediated export [3]. Furthermore, we observed that TAP/NXF1
is also required for the correct expression of some VZV genes
involved in virions assembly. Thus, although the viral targets have
to be further characterized, we suggested that IE4, through its
interaction with the SR proteins, is able to access the export TAP/
NXF1 pathway to carry some speciﬁc VZVmRNAs to the cytoplasm.
7. Their functions in the RNA alternative splicing
ICP27was previously shown to post-transcriptionally stimulate
mRNA accumulation from a transfected viral late gene encoding
the glycoprotein C (gC) [47]. Further studying this observation, it
was observed that the gCmRNA produced by ICP27 transactivation
is an unspliced form, due to the retention of a previously
undescribed intron from the gC transcript [48]. Contrastingly,
during a viral infection, both transcripts and both proteins are
detected, and it appears that HSV-1 has evolved to express two
versions of the gC transcript. The spliced transcript encodes a
variant of the glycoprotein C that lacks its transmembrane domain
and that is efﬁciently secreted from infected cells, suggesting that
it could function as a virulence factor. As ICP27 has been previously
shown to inhibit cellular mRNA splicing during infection, this gC
intron retention function could simply reﬂect a non-speciﬁc
suppression of splicing. Alternatively, this ability of ICP27may be a
transcript- or intron-speciﬁc effect and not the result of a general
inhibition of mRNA splicing. Although still to be conﬁrmed, the gC
gene could harbour a silencing element in its 50 half, distinct from
the intron, and the effects of this sequence could be overcome by
ICP27. The same authors also showed that IE4 lacks this ICP27
capacity of alternative splicing and is not able to promote HSV-1 gC
intron retention [48].
Also very recently, EB2was shown to induce alternative splicing
of a cellular RNA transcript, suggesting that viruses may also
regulate cellular gene expression at the level of alternative splicing.
As mentioned above, when expressed in EBV-negative cells, EB2
has a broadly inhibitory effect on cellular mRNA accumulation.
Nevertheless, EB2 causes several cellular transcripts to accumulate
at higher levels [49]. These transcripts include STAT1 and several
interferon (IFN)-stimulated genes. The STAT1 protein is a central
mediator of both type I (IFN-a/b) and type II (IFN-g) IFN signal
transduction pathways. It is expressed as two isoforms, STAT1a
and STAT1b. STAT1b mRNA is generated by cleavage and
polyadenylation at an alternative site in the last intron of the
STAT1 pre-mRNA, and, as the produced protein lacks the trans-
activating domain encoded in the last exon, STAT1b acts as a
dominant-negative repressor of STAT1a. EB2 was shown to
disproportionately increase the relative amount of STAT1bmRNA
[49]. More precisely, EB2 was identiﬁed to induce the alternative
splicing of STAT1 at a novel 50 splice site (Alt 50SS), resulting in a
STAT1a0 mRNA incapable of producing STAT1a (Fig. 5A) [50]. EB2
was shown to act as a splicing factor by directly binding to the
same STAT1 RNA region as ASF/SF2 and to compete with this
splicing factor in the splice site selection. By increasing the
STAT1b/STAT1a RNA ratio, EB2 changes the relative levels of ISGs
depending on how responsive they are to STAT1b, which affects
cellular apoptosis and resistance to viral infection. As we showed
that IE4 directly interacts with ASF/SF2, we here wondered if IE4
also shares this novel EB2 function. We used the STAT1 minigene
construct for in vivo splicing assay (Fig. 5B). HeLa cells were co-
transfected with this reporter plasmid and an IE4- or its
homologues-encoding vector. Total RNAs were extracted and
STAT1 transcripts were observed by RT-PCR using speciﬁc primers
amplifying both alternatively spliced products (a or a0). We
showed that EB2 is the unique homologue able to alternatively
[(Fig._5)TD$FIG]
Fig. 5. IE4 and its homologues in the alternative splicing of the STAT1 RNA. (A)
Schematic representation of the STAT1 minigene (adapted from Ref. [50]) which
contains STAT1 exon 23, exon 24 and intervening sequence. Alternative processing
events generate either the a or the a0 spliced form, in which the a 50 donor site is
skipped and the a0 50 donor site is used (Alt50SS). (B) HeLa cells were transfected
with the STAT1 minigene and expression plasmids as indicated (lanes 2–6).
Untransfected cells were used as a negative control (lane 1). Total RNAs were
isolated from transfected HeLa cells by TriPure/chloroform (Roche) extraction and
isopropanol precipitation. A DNase treatment with DNase I recombinant RNase free
(Roche) was performed according to the manufacturer’s protocol to digest any DNA
contamination from RNA preparations. Reverse transcription was performed with
1mg of puriﬁed total RNAs by use of M-MLV Reverse Transcriptase and Random
Primers (Invitrogen) for 1 h at 37 8C. PCRs were performed on 2 ml of cDNAs using
GoTaq DNA polymerase (Promega) and speciﬁc primers (STAT1_FW 50-
TGGAAAGCGTACACAATGTGT-30 and STAT1_RV 50-CATACTGTCGAATTCTACAGA-
30) amplifying both alternatively spliced products (a or a0). The PCR-ampliﬁed
products were then analysed on 1% agarose gel and visualized by ethidium bromide
staining. Reverse transcription without reverse transcriptase (RT, lane 7) was
performed as purity control of our RNAs and GAPDH PCR was used as input control
(GAPDH_FW 50-CATCACTGCCACCCAGAAGACTGTGGA-30 and GAPDH_RV 50-
TACTCCTTGGAGGCCATGTAGGCCATG-30). The expression of the different proteins
was veriﬁed by Western blotting using anti-V5 and anti-Flag antibodies.
I. Ote et al. / Biochemical Pharmacology 80 (2010) 1973–1980 1977splice this STAT1 gene, and that the presence of either IE4, or ICP27
and UL69, only leads to the constitutively spliced STAT1 mRNA.
8. Their regulation by phosphorylation
As these four proteins are known to be phosphoproteins, it had
been speculated that their activities could be regulated through
phosphorylation. Very recently, two studies simultaneously
highlighted a link between the cellular CDKs activity and the
UL69 localization and functionality [51,52]. Furthermore, the
HCMV protein kinase UL97, which had been characterized as a
CDK-related kinase, was also shown to modulate the nuclear
localization and activity of UL69. UL69 was shown to physically
interact with UL97 and to co-localize with CDK9. In addition, UL69
acts as a speciﬁc substrate in in vitro kinase reactions with the viral
kinase UL97 and all the CDKs analyzed (CDK-1, -2, -7 and -9).
Interaction studies showed that UL97 interacts with the UL69 N-
terminus, which consists of multiple overlapping functionally
important regions, such as the NLS, the UAP56/URH49 interaction
motif and the RNA binding site, as well as with the UL69 C-
terminus, which contains the NES. Therefore, phosphorylation
within these domains may trigger a ﬁne-regulation of the distinct
properties of UL69. Indeed, UL97-mediated phosphorylation of
UL69 was demonstrated to enhance the latter’s mRNA export
activity, and protein kinase inhibitors, such as Go¨6976 (UL97) androscovitine or R58 (CDKs), signiﬁcantly reduce this activity. Thus,
cellular CDKs and viral UL97 activities are required tomodulate the
intranuclear localization andmRNA export function of UL69 during
HCMV replication.
Similarly, it has been shown that the protein kinase CK2a andb
subunits interact in vitro both individually, and more efﬁciently as
a complex, with EB2 N-terminal and C-terminal domains [53].
Furthermore, EB2 was shown to co-immunoprecipitate from living
cells with CK2. This latter was also shown to phosphorylate several
residueswithin EB2N-terminus, including the Ser-55, -56, and -57,
which localize next to the EB2 NES. The phosphorylation mutant
EB2S3A was shown to be unable to trans-complement EB2 in cells
harboring an EB2-defective EBV genome. This defect is not due to
an impaired nucleocytoplasmic shuttling but associated with a
decreased cytoplasmic accumulation of several late viral mRNAs.
These results suggest that the CK2-mediated EB2 phosphorylation
is crucial for the production of EBV infectious virions.
ICP27 has also been demonstrated to be phosphorylated on
serine residues during infection. Two serine residues at positions
16 and 18 within the leucine-rich N-terminal region required for
export were shown to be phosphorylated by CK2, and a serine at
position 114 within the NLS was identiﬁed to be targeted by PKA
[54]. As the S114A mutation diminishes the ICP27 import into the
nucleus, it was suggested that the phosphorylation by PKA may
regulate the ability of ICP27 to interact with importins. All ICP27
phosphorylation mutant viruses were also shown to reach lower
growth curves compared to wild type HSV-1, further suggesting a
role of phosphorylation in the various ICP27 functions during viral
infection, including its shuttling and RNA export activities
(reviewed in Ref. [41]). Recently, the ICP27 phosphorylation
mutants at Ser-16, -18, and -114 residues were shown to display
altered functional interactions with Aly/REF and TAP/NXF1,
although they are still able to bind HSV-1 mRNAs [55].
Interestingly, these mutants were also described to be defective
in HSV-1 replication and viral gene expression [56].
SRPK1 is the main serine/threonine-protein kinase that speciﬁ-
cally phosphorylates the SR proteins [57]. Through these phosphor-
ylation events, SRPK1 regulates the localization and functions of the
SR proteins, as well in constitutive and alternative splicing as in
mRNAs export and translation (reviewed in Ref. [58]). As already
mentioned, ICP27was shown to interactwith SRPK1, aswell aswith
SRp20 and other SR proteins [59]. ICP27 is also phosphorylated by
this kinase and several explanations for the ICP27-mediated SR
protein hypo-phosphorylation have been suggested. ICP27 could
simply competewith SR proteins for the SRPK1 binding, couldmask
potential phosphorylation sites in SR proteins, or could alter the
SRPK1 conformation resulting in changes of its activity. These
possibilities are not mutually exclusive and all result in splicing
inhibition by impairing spliceosome assembly.
Similarly, we showed that IE4 interacts with SRPK1, mainly
through its Rb domain [3]. We also showed that the Ser-136
residue located in this region is phosphorylated by the kinase.
However, we were not able to demonstrate the role of this
phosphorylation in the export activity of IE4. It could be implicated
in the nuclear reimport of IE4, like it has been suggested for the SR
proteins [30], or even be involved in the regulation of other still
unknown functions of IE4. The in silico analysis of IE4 also predicts
many phosphorylation sites for the CK2, PKA and PKC kinases, but
no role of these potential phosphorylation events on the IE4
activities has been studied so far.
9. The IE4-mediated recruitment of the TAP/NXF1 receptor
SRp20 and 9G8 were shown to recruit TAP/NXF1 through a
small arginine-rich peptide next to their RNA recognition motifs
(RRMs) rather than through their C-terminal RS domains [29].
[(Fig._6)TD$FIG]
Fig. 6. Model of recruitment of TAP/NXF1 by IE4 in a SR proteins- and RNA-
dependent way. (A) In absence of RNA, IE4 and the SR proteins interact through the
Ra, Rb, Rc domains of IE4 and a small peptide next to the RRMs of SR proteins. (B) In
presence of RNA, a conformation change of the SR proteins allows the recruitment
of TAP/NXF1. (C) IE4 binds TAP/NXF1 through its C-terminus leading to a tripartite
export-competent complex.
I. Ote et al. / Biochemical Pharmacology 80 (2010) 1973–19801978Although it was not determined, it is convincible to think that, in
absence of RNA, the interaction between IE4 and the SR proteins
occurs through the Ra, Rb, Rc domains of IE4 and this small peptide
(Fig. 6A). By contrast, in presence of RNA, the RNA-binding
domains of these proteins would preferentially interact with the
transcript, leading to a conformation change of the SR proteins and
allowing the small peptide to recruit TAP/NXF1 (Fig. 6B).
Interestingly, we showed that the C-terminal cystein-rich region
of IE4 is also required for its export activity since the IE4Dcys
mutant was shown to be incompetent in a reporter export assay
[3]. Since IE4 seems to dimerize through this C-terminal region, the
dimerization of IE4 could be a prerequisite to its function.
However, it was shown that ICP27 interacts with TAP/NXF1 via
its C-terminus, which contains a zinc ﬁnger-like domain (CCHC)
[33]. Such a potential zinc ﬁnger domain is also present in the C-
terminal region of IE4 [7]. We could thus hypothesize that the
presence of RNA and the recruitment of TAP/NXF1 by the SR
proteins would allow the C-terminal part of IE4 to bind TAP/NXF1,
and that only these tripartite complexes would be competent for
export (Fig. 6C). This model would support our data showing that
the recruitment of TAP/NXF1 by IE4 is RNase-sensitive. Further-
more, IE4 was shown to be essential for VZV replication and more
precisely the GKYFKC motif contained in the IE4 C-terminal region
was shown to be crucial [60]. Thus, the role of IE4 as export adaptor
and its capacity to access the TAP/NXF1 pathway could be
indispensable for the VZV infection.
10. IE4 and its homologues as alternative targets in
antiherpetic therapies
So far, majority of the antiherpetic agents are based onmodiﬁed
nucleoside analogues such as the currently available drugs
acyclovir and gancyclovir. These drugs are competitively incorpo-
rated into viral DNA, what further blocks the DNA polymerase
activity and inhibits the viral replication. However, over the past
few years, the long-term usage of these antiviral agents led to the
emergence of nucleoside-analogue-resistant herpesvirus strains,
resulting in ineffective conventional therapies (reviewed in Ref.
[61]). Additional antiherpetic treatments, such as various anti-
sense-mediated strategies, are therefore under development, in
order to speciﬁcally knockdown expression of some viral proteins.
On the basis of their crucial roles in the infectious cycle, the viral
export factors described here must be considered as targets in
these novel therapeutic approaches. Recently, the antiviral activity
of peptide-conjugated phosphorodiamidatemorpholino oligomers
(PPMO) was investigated in HSV-1 ocular infection [62]. PPMO
targeting ICP27 were shown to inhibit viral replication both in cellcultures and in eyes of mice. Since the antisense technique is in
theory unlimited and that these PMO present pharmacological
advantages compared to other antisense oligonucleotides, this
novel technology could be further developed as alternative
antiherpetic therapy.
In addition to target speciﬁc viral proteins, several recent
studies suggest to exploit the cellular proteins as potential targets
for the development of novel antiviral agents. Targeting a host
factor may be a useful tool to avoid the emergence of mutant
resistant strains. However, inhibition of multifunctional cellular
proteins could more largely deregulate the host cell signalling
pathways andmight result in signiﬁcant undesirable effects. In the
mRNA export pathway, rather than targeting the essential TAP/
NXF1 receptor, the safest strategy would be to knockdown UAP56
or the shuttling SR proteins, which are the speciﬁc cellular proteins
targeted by UL69 or IE4 in HCMV and VZV infection respectively
[3,35]. Similarly, the speciﬁc knockdown of the DEAD-box RNA
helicase DDX3 was shown to inhibit HIV-1 replication without
affecting cell viability [63].
In addition to inhibit expression of these viral export factors, or
expression of their cellular partners, antiviral drugs targeting their
speciﬁc functions and regulation could also be developed. As all
these proteins are regulated by phosphorylation, kinase inhibitors
are promising key agents in antiviral therapies. Thus, similarly to
roscovitine that was shown to reduce CDKs-mediated UL69
activity [51], speciﬁc inhibitors of CK2 or SRPK1 could potentially
reduce ICP27, IE4 or EB2 export functions. Furthermore, viral
kinases also represent potential targets in antiherpetic treatments.
For example, maribavir, a selective inhibitor of the UL97 kinase
[64], is currently under phase III clinical trial to treat HCMV
infections.
Finally, example could be taken from the prototypical viral
export factor HIV-1 REV protein, which has already been targeted
in clinical trial. Indeed, in the anti-HIV gene-therapy study, the
lentiviral vector transduction of a dominant-negative REV protein
was shown to potently inhibit HIV-1 replication [65]. Thus, various
mutants of the herpesviral export factors, impaired in their
capacity of either nucleocytoplasmic shuttling, RNA-binding, or
cellular proteins interaction, could be tested in their ability to act
as dominant-negative inhibitors, thus corresponding to good
candidates of protein-based agents in alternative antiherpetic
therapies.
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